The US government is reportedly considering taking a stake in Intel.
Posts from this topic will be added to your daily email digest and your homepage feed. See All Intel
Posts from this topic will be added to your daily email digest and your homepage feed. See All News
Posts from this topic will be added to your daily email digest and your homepage feed. See All Policy
Posts from this topic will be added to your daily email digest and your homepage feed. See All Politics
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Tech
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Insiders Snap Up These 2 Stocks on the Dip — Here's Why They Draw Plaudits from Goldman Sachs
Every investor looks for signs that a stock might be worth the leap. While no single indicator guarantees success, some signals stand out as especially powerful when they appear together. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. One of the most reliable is insider buying. These are high-level executives and directors who have an intimate understanding of their company's operations, prospects, and challenges. They tend to put their own money on the line only when they believe the stock's future value will be higher. Better yet, their trades must be disclosed publicly, giving everyday investors a chance to watch and follow their moves. Another time-tested signal is the 'buy low, sell high' principle, spotting beaten-down stocks that have been oversold and may be poised for recovery. Price declines can sometimes signal trouble, but they can also reflect market overreactions, offering attractive entry points for those willing to look past the noise. The picture gets even stronger when this combination is validated by a heavyweight endorsement from Wall Street. A Buy rating from a firm like Goldman Sachs is more than an opinion – it's typically backed by deep research, robust industry modeling, and high-conviction guidance to clients. Such endorsements can boost investor confidence and help catalyze momentum. Against this backdrop, we've used the TipRanks database to pinpoint two stocks where all three forces align: insiders are buying, valuations look attractive after recent pullbacks, and Goldman Sachs is flashing a green light. When these signals converge, it's a setup that few investors can afford to ignore. Shift4 Payments (FOUR) We'll start our look at insider buying with Shift4 Payments, a payment processing company based in Pennsylvania that traces its roots back to 1999, when a teenage Jared Isaacman launched it from his parents' basement. His mission was to fill an 'efficiency niche' in payment processing by reducing the time and cost for merchants to get up and running. Today, the company sports a market cap approaching $8 billion and generates more than $3 billion in annual revenue. Over the years, Shift4 has expanded well beyond its early merchant focus. Its payment processing solutions now cater to customers across a wide range of industries, marketed as simple, safe, scalable, and smart – and tailored to individual client needs. Complementing these services, Shift4 offers point-of-sale systems, contactless commerce, and mobile payment capabilities. With offices across North America and Europe, the company supports over 100 payment methods in more than 150 currencies worldwide. That global reach got another boost on July 3, when Shift4 completed its $2.5 billion acquisition of Global Blue, a specialty payments and tech platform focused on international transactions, including tax-free shopping and currency conversion. The deal, priced at $7.50 per share, further strengthens Shift4's ability to serve cross-border clients. Such moves have helped the company build an impressive footprint: more than 200,000 customers, 500-plus technology integrations, and over 5 billion annual transactions totaling more than $260 billion. Yet, despite this strong operational base, the stock is down 14% year-to-date. The most recent spate of losses came after the August 5 earnings release for 2Q25. In that release, Shift4 showed quarterly revenues of $966.2 million, a figure that was up nearly 17% year over year but missed the forecast by just over $12 million. At the bottom line, the company's non-GAAP EPS of $1.10 also missed the forecast, coming in 10 cents per share lower than had been expected. Following the post-earnings pullback, founder and chairman Jared Isaacman moved quickly to buy the dip, scooping up 196,426 Shift4 shares between August 8 and August 11 for nearly $16.27 million, a move that signals strong confidence in the company's long-term prospects. That conviction appears to be shared on Wall Street, with Goldman Sachs analyst Will Nance viewing Shift4 as a potential growth story. 'We view FOUR as one of the top growth stories in our coverage and are constructive on the company's unique approach to M&A that has resulted in FOUR maintaining high levels of growth without incurring outsized customer acquisition costs. We expect this M&A strategy to continue, both in existing markets and increasingly in international markets. On that note, we believe that the Global Blue deal represents a solid addition to the company's customer acquisition funnel in Europe, and expect that FOUR has the potential to exceed its top line revenue synergy targets as it targets the low end of the Global Blue customer base, a group that historically relies on bank and legacy payment processors,' Nance opined. 'Importantly,' the analyst added, 'we believe FOUR can achieve these targets without any major enterprise wins, which we think is a common point of misunderstanding in the market, as some investors perceived the deal as FOUR looking to compete head to head with modern enterprise processors such as Adyen.' Quantifying this stance, Nance rates FOUR shares as a Buy, with a $104 price target that implies a ~17% upside for the coming year. (To watch Nance's track record, click here) Overall, Shift4's stock holds a Strong Buy consensus rating, based on 22 analyst reviews that include 17 Buys against 5 Holds. The shares are priced at $89.11, and their $107.75 average price target indicates room for a ~21% gain on the one-year horizon. (See FOUR stock forecast) Vertex Pharmaceuticals (VRTX) The next stock that has the combination of strong insider buys, a share price on the dip, and a bullish nod from Goldman Sachs is Vertex Pharmaceuticals. This company is a biotech researcher, with both a pipeline of drug candidates under development and a portfolio of approved medications on the market. That combination is something of a 'Holy Grail' for biotechs – and Vertex has reaped the rewards. The company was founded in 1989 and has since built itself into a $100 billion player in the field. Vertex's portfolio currently includes seven approved medications, and the company generated revenues of $11 billion last year and nearly $10 billion in 2023, with the bulk of that revenue coming from product sales. Vertex's product portfolio includes Trikafta, its largest revenue generator, which is a treatment for cystic fibrosis, and Kalydeco, another cystic fibrosis treatment, which was approved in 2012 and is Vertex's first approved drug. The company's most recently approved drugs are Casgevy, a treatment for sickle cell disease, approved in 2023; Alyftrek, a CF treatment for patients over age 6, approved in 2024; and Journavx, a non-opioid pain treatment approved in January of this year. The company's commercialized medications provided the bulk of its $2.96 billion in total quarterly revenue in 2Q25, the last period reported; of that total, $2.55 billion came from sales of Trikafta. Vertex's strong revenue totals support its research pipeline, under which the company continues to develop treatments for a wide range of conditions, including kidney disease, severe pain, beta thalassemia, and diabetes, as well as additional treatments for cystic fibrosis and sickle cell disease. The latest news about the company came from that development program, specifically as it relates to VX-993, a treatment for acute pain that was the subject of a recently completed Phase 2 clinical trial. On August 4, the same day that the company released its 2Q25 results, Vertex also announced that VX-993 failed to meet the primary endpoints of the study and will not be developed further as an acute pain monotherapy. The stock price has dropped sharply since that day and has not recovered; it is still down by 17%. That drop has not gone unnoticed in the C-suite. On August 6, two top insiders made substantial purchases: President and CEO Reshma Kewalramani bought 10,000 shares for nearly $3.9 million, and board member Bruce Sachs acquired 5,000 shares for $1.95 million. Goldman Sachs analyst Salween Richter shares that conviction, pointing to the company's expanding lineup of commercial products and the strength of several clinical-stage candidates. 'We recommend owning VRTX on continued commercial execution as demonstrated by the recent launches of Alyftrek in cystic fibrosis, noting a majority of treated patients are switch patients, and Journavx in acute pain, ahead of a 2H inflection, where we acknowledge access/reimbursement progress (inclusive of two of the three largest PBMs – the last is expected by YE); and potential emergence of a third commercial lever in povetacicept, where an interim analysis of the Ph3 RAINIER trial in IgA nephropathy (IgAN) could support an accelerated approval filing in 1H26, with expansion into other autoimmune renal diseases and cytopenias,' Richter wrote. Richter goes on to rate VRTX stock as a Buy and sets a $624 price target that indicates room for an upside of ~60% by this time next year. (To watch Richter's track record, click here) Overall, shares in Vertex hold a Moderate Buy consensus rating, based on 27 recent analyst reviews that split to 16 Buys and 11 Holds. The stock is priced at $390.30, and its average price target, now at $491.78, suggests a one-year upside potential of 26%. (See VRTX stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
3 High-Growth Dividend Stocks That Could Explode Higher in 2025
After trading for nearly 30 years, one of the best things I've learned is that it pays to be picky when looking for income-generating stocks. Sure, high yields are attractive, but a company that has high yields and the ability to sustain them is worth its weight in gold. Even better if such companies have a good track record of increasing dividends, preferably consecutively. Now, there are groups of companies like Dividend Aristocrats and Kings that already offer the qualities I like. But that doesn't mean we need to limit ourselves to those top-shelf companies. Sometimes, there are dividend-paying gems exhibiting high growth, low payout ratios, and decent yields that are waiting on the sidelines. More News from Barchart UnitedHealth Stock Soars as Warren Buffett's Berkshire Hathaway Discloses $1.57B Stake Insiders Just Grabbed Nearly $1M of This High-Yield Energy Stock This Dividend Stock Just Hit New All-Time Highs Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Today, I'll be reviewing my list of notable dividend stocks to see which ones meet my stringent criteria for high yields and high growth. How I Came Up With The Following Stocks As usual, I fired up Barchart's Stock Screener tool and used the following filters: Annual Dividend Yield: Left blank so I can sort the list using this criterion. Current Analyst Rating & Number of Analysts: 3.5 (Moderate Buy) to 5 (Strong Buy), and 16 or above. This combination ensures I get companies that have Wall Street's (generally) positive regard. 5-Year Dividend Growth: 50% and above. This filter compares the company's payouts from five years ago to the current ones. On average, a 50% growth rate represents a 10% growth annually, which is considered strong and sustainable for many mature businesses. Dividend Payout Ratio: 65% or less. The payout ratio shows how much the company uses of its earnings to pay dividends. 65% is on the high end of what many consider the 'healthy' range. Watchlists: As someone who loves dividend stocks, I maintain several dividend-centric watchlists that I now use for this search. These include the Dividend Contenders, Aristocrats, Kings, high-yield stocks, growth stocks, and monthly dividend stocks. I ran the screen and got 28 companies, which I then arranged from highest to lowest yields: Now, I'll take the top three and discuss each one, starting with number one: Best Buy Company (BBY) First up is Best Buy Company (NYSE:BBY), a multinational consumer electronics retailer that sells a wide range of products, including computers, smartphones, televisions, home appliances, video games, and related accessories. The company has over 1000 stores in the US and Canada alone, and now operates an online platform that offers the same extensive product selection, along with convenient delivery, pickup, and customer support services. Best Buy currently pays 95 cents per share quarterly, which works out to $3.80 per year and around a 5.29% yield. Aside from the high yield, the company also boasts a relatively healthy dividend payout ratio of 59.14% and an 88% 5-year dividend growth rate. Even more impressive, the company has increased dividends since 2004, for 22 straight years. Three more years of increases, and Best Buy will become a Dividend Aristocrat! Analysts also rate BBY stock a Moderate Buy. Comcast Corp A (CMCSA) Comcast Corporation (NASDAQ:CMCSA) is one of the biggest global media and technology companies in the United States, offering services that range from cable television and high-speed internet to wireless communications and home phone solutions. In the last few decades, it also started acquiring large-scale networks and communications providers, including NBCUniversal, Sky, and various regional sports and entertainment networks. The company pays $1.32 in dividends annually, translating to around a 4% yield based on the stock's last closing price. Dividends have increased 93.65% in the last five years, while Comcast currently has an impressive 28.15% payout ratio despite its relatively high yield. It also has an 18-year dividend increase streak, and today, CMCAS stock has a Moderate Buy rating. Regions Financial Corp (RF) Last but not least is Regions Financial Corporation (NYSE:RF), a banking and financial services company that operates primarily in the Southern and Midwestern United States. It offers a full range of services, including personal and business banking, mortgage and lending products, wealth management, and insurance solutions. Regions Financial has a long and storied history of paying dividends - since 1989. The company increased its payouts until it went stagnant between 2000 and 2004 at 33 cents quarterly, around the time when the dot-com bubble burst and the markets were recovering. It picked up the pace after that, but then the global financial crisis hit, and it was forced to cut dividends to 1 cent a share quarterly. Since 2013, however, the company has continued increasing its dividends, with the most recent one being $1.00 per share per year, which reflects around a 3.8% yield. Regions Financial has increased its dividend by 66.10% over the last five years, and its current dividend payout ratio is a healthy 41.16%. Meanwhile, analysts rate RF stock a Moderate Buy. Final Thoughts Looking for long-term dividend stocks is not just about yields. You need to look at the company's ability to maintain its payments, check if the current levels are at risk of cuts, and determine whether its financial performance, industry position, and growth prospects can support consistent dividend increases in the future. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
